Literature DB >> 28099951

Complex X-Chromosomal Rearrangements in Two Women with Ovarian Dysfunction: Implications of Chromothripsis/Chromoanasynthesis-Dependent and -Independent Origins of Complex Genomic Alterations.

Erina Suzuki1, Hirohito Shima, Machiko Toki, Kunihiko Hanew, Keiko Matsubara, Hiroki Kurahashi, Satoshi Narumi, Tsutomu Ogata, Tsutomu Kamimaki, Maki Fukami.   

Abstract

Our current understanding of the phenotypic consequences and the molecular basis of germline complex chromosomal rearrangements remains fragmentary. Here, we report the clinical and molecular characteristics of 2 women with germline complex X-chromosomal rearrangements. Patient 1 presented with nonsyndromic ovarian dysfunction and hyperthyroidism; patient 2 exhibited various Turner syndrome- associated symptoms including ovarian dysfunction, short stature, and autoimmune hypothyroidism. The genomic abnormalities of the patients were characterized by array-based comparative genomic hybridization, high-resolution karyotyping, microsatellite genotyping, X-inactivation analysis, and bisulfite sequencing. Patient 1 carried a rearrangement of unknown parental origin with a 46,X,der(X)(pter→ p22.1::p11.23→q24::q21.3→q24::p11.4→pter) karyotype, indicative of a catastrophic chromosomal reconstruction due to chromothripsis/chromoanasynthesis. Patient 2 had a paternally derived isochromosome with a 46,X,der(X)(pter→ p22.31::q22.1→q10::q10→q22.1::p22.31→pter) karyotype, which likely resulted from 2 independent, sequential events. Both patients showed completely skewed X inactivation. CpG sites at Xp22.3 were hypermethylated in patient 2. The results indicate that germline complex X-chromosomal rearrangements underlie nonsyndromic ovarian dysfunction and Turner syndrome. Disease-causative mechanisms of these rearrangements likely include aberrant DNA methylation, in addition to X-chromosomal mispairing and haploinsufficiency of genes escaping X inactivation. Notably, our data imply that germline complex X-chromosomal rearrangements are created through both chromothripsis/chromoanasynthesis-dependent and -independent processes.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28099951     DOI: 10.1159/000455026

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  7 in total

Review 1.  Chromoanagenesis: a piece of the macroevolution scenario.

Authors:  Franck Pellestor; Vincent Gatinois
Journal:  Mol Cytogenet       Date:  2020-01-28       Impact factor: 2.009

2.  Stable transmission of complex chromosomal rearrangements involving chromosome 1q derived from constitutional chromoanagenesis.

Authors:  Mary A Gudipati; Elizabeth Waters; Carol Greene; Nidhi Goel; Nicole L Hoppman; Beth A Pitel; Matthew R Webley; Ying Zou
Journal:  Mol Cytogenet       Date:  2019-10-31       Impact factor: 2.009

3.  Methylation status of genes escaping from X-chromosome inactivation in patients with X-chromosome rearrangements.

Authors:  Sayaka Kawashima; Atsushi Hattori; Erina Suzuki; Keiko Matsubara; Machiko Toki; Rika Kosaki; Yukihiro Hasegawa; Kazuhiko Nakabayashi; Maki Fukami; Masayo Kagami
Journal:  Clin Epigenetics       Date:  2021-06-30       Impact factor: 6.551

Review 4.  Chromoanagenesis: cataclysms behind complex chromosomal rearrangements.

Authors:  Franck Pellestor
Journal:  Mol Cytogenet       Date:  2019-02-11       Impact factor: 2.009

5.  Heterozygous Deletion of the SHOX Gene Enhancer in two Females With Clinical Heterogeneity Associating With Skewed XCI and Escaping XCI.

Authors:  Yixi Sun; Yuqin Luo; Yeqing Qian; Min Chen; Liya Wang; Hongge Li; Yu Zou; Minyue Dong
Journal:  Front Genet       Date:  2019-11-06       Impact factor: 4.599

6.  Clinical case report: A case of Turner syndrome with Graves' disease.

Authors:  Hongmin Zhang; Xingyu Zhang; Mei Yang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

Review 7.  Insight into the Molecular Basis Underlying Chromothripsis.

Authors:  Katarzyna Ostapińska; Borys Styka; Monika Lejman
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.